SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic,…
Month: January 2025
NEW YORK, Jan. 2, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Jan. 2, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…